Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
Grant valued at $568,000 awarded for the study of brain tumours
August 18, 2014
Dr.
Ian Lorimer
has been awarded a four year grant valued at $567,572 by the
Canadian Institutes of Health Research
(CIHR) to study an aggressive and incurable form of brain tumour known as glioblastoma. About 1,700 Canadians die from brain tumours each year. Most of these deaths are due to the aggressive and incurable glioblastoma tumour. Dr. Lorimer’s research seeks to develop effective treatments for this disease. Specifically, Dr. Lorimer will determine whether a protein known as PKCiota is a valid target for glioblastoma therapy. This will be tested in clinically relevant models of glioblastoma that were created using cells isolated from patients undergoing surgery for glioblastoma at The Ottawa Hospital. To validate PKCiota as a target for glioblastoma therapy, Dr, Lorimer and his team will genetically modify these patient cells in ways that impair PKCiota function. The cells will then be introduced into the brains of mice and the effects on the aggressiveness of the cancer cells will be determined. This will help to assess the overall feasibility of this therapeutic strategy in the brain tumour patient population.
About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.
Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)